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Background: Primary lymphoma of bone (PLB) is a rare disease, comprising a malignant lymphoid
inﬁltrate of bone. The goal of this study was to identify socioeconomic, demographic, and anatomic
factors as prognostic indicators of survival for this disease using the Surveillance, Epidemiology, and End
Results (SEER) database.
Methods: The SEER database was used to identify a study population of 692 patients diagnosed with PLB
in the United States from 1989 to 2003. Survival was analyzed using the Kaplan–Meier method, with
effects of potential prognostic factors on survival analyzed using the log-rank test. Multivariable analysis
was performed by Cox proportional hazards regression.
Results: The overall 5-year survival rate was 49.6%, with a 10-year survival rate of 30.2%. Median overall
survival was 4.9 years (95% CI: 3.9, 6.1). In multivariable analysis, age (po0.0001), marital status
(p¼0.006), and appendicular vs. axial tumor location (p¼0.004) were found to be independent
predictors of survival.
Conclusions: This population-based study of PLB identiﬁed age, marital status, and tumor location as
independent indicators of prognosis. This ﬁnding supports the clinical suspicion that an appendicular
tumor location confers a better prognosis than an axial tumor location.
& 2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
The rare disease now known as primary lymphoma of bone
(PLB) was initially described by Oberlin [1]. Parker and Jackson
later described PLB as a distinct entity [2], which is understood to
be a malignant lymphoid inﬁltrate of bone [3]. While this may
include cortical or soft tissue invasion, the diagnosis generally
excludes lymph node or distant visceral involvement to be
considered a primary lymphoma of bone [4]. This deﬁnition has
been contended throughout the literature, with some authors
permitting lymph node involvement [5–7], though most authors
recognize the disease as lymphoma localized only to bone upon
diagnosis.
Primary lymphoma of bone affects 1.7/1,000,000 patients in the
US [8]. Previous studies have suggested PLB comprise 5% of all
extranodal lymphomas [9], and 3% of all bone malignancies [10].
Due to the low incidence of PLB, most prior studies have been from
a single-institution, and have had small sample sizes [10–15]. The
Surveillance, Epidemiology, and End Results (SEER) database is a
publically available database created for the purpose of collecting
demographic, clinical, and outcome data for cancer patients in the
United States. There remains scant literature published using this
database to evaluate larger patient populations [8].
The purpose of this population-based study was to identify
prognostic factors for survival in patients with PLB, in order to
determine whether disparities in survival exist between demo-
graphic cohorts. In doing so, the current study aimed to determine
the prognostic signiﬁcance of different tumor-speciﬁc and ana-
tomic considerations that may inﬂuence overall survival from this
disease. The authors chose to limit this study to adult patients,
because PLB in children is often considered and treated as a
systemic disease [16].
2. Material and methods
The study population was selected from the National Cancer
Institute’s SEER database. The SEER database collects data from 18
geographic registries, covering approximately 28% of the U.S.
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population [17]. The SEERnStat software (Version 8.0.4; NCI;
Bethesda, MD) was used to identify 997 adult patients diagnosed
with primary lymphoma of bone during a 15-year period from
1989 to 2003. Histology was selected by using ICD-O-3 codes
9590/3, 9591/3, 9670/3, 19671/3, 9675/3, 9680/3, and 9684/3.
Primary site was selected as C40.0, C40.1, C40.2, C40.3, C40.8,
C40.9, C41.2, C41.3, C41.4, and C41.9. Exclusion criteria included
lesions of the skull and face, T-cell lymphoma, and cases without
follow up data, yielding a ﬁnal study population of 692 patients.
Tumor location was dichotomized as either appendicular or
axial. The scapula was considered to be part of the appendicular
skeleton, while the pelvic bones were considered to be part of the
axial skeleton. Marital status was categorized as single, married, or
other (including separated, divorced or widowed). Rural–urban
continuum code was collapsed into a binary variable: Metro
county or non-metro county, using guidelines by SEER and the
Economic Research Service [18,19]. SEER registry region was
aggregated into regions (Northeast, South, Southwest, Midwest,
and West). Race was categorized as White, Black or Asian/Other.
Age was considered as a categorical variable (o30 years, 30–59
years, Z60 years).
Statistical analysis was performed in SAS version 9.3 (SAS
Institute, Cary, NC). The effects of categorical variables on survival
were assessed by computing Kaplan–Meier product limit curves
and compared using the log-rank test. The effects of continuous
variables were analyzed using Cox proportional hazards regres-
sion. The Bonferroni method was applied when performing multi-
ple comparisons. Factors that appeared to be signiﬁcantly
associated with survival in the univariate analysis were considered
for inclusion in the ﬁnal multivariable Cox proportional hazards
regression model. A result was considered statistically signiﬁcant
with a p-value o0.05. Efron’s method was used to adjust for tied
failure times.
Incidence rates were age-adjusted to the 2000 US standard
population, with conﬁdence intervals calculated using the Tiwari
modiﬁcation. Annual percentage change was calculated using the
weighted least squares method.
3. Results
The ﬁnal analysis included 692 patients, whose demographic
and clinical characteristics are presented in Table 1. The majority
of patients were white (89.0%), non-Hispanic (91.3%), and lived in
metropolitan counties (87.4%). The majority of patients were over
the age of 60 years (55.6%), and diffuse large B-cell lymphoma was
the most common histologic classiﬁcation (71.2%). The western
region of the United States contributed the largest proportion of
patients to the study population (56.5%).
The estimated overall survival of patients for all patients in this
study was 49.6% at 5-years, and 30.2% at 10-years (Fig. 1). The
incidence of PLB during the 15-year study period ranged from 0.1/
100,000 to 0.3/100,000 (Fig. 2). The annual percent change for this
time period was non-signiﬁcant, suggesting a stable incidence
over the study period.
In univariate analysis, signiﬁcant factors for overall survival
included age (po0.0001), marital status (po0.0001), anatomic
location of tumor (po0.0001), geographic region (p¼0.02), and
tumor grade (p¼0.01). After Bonferroni adjustment, tumor grade
was no longer a signiﬁcant prognostic indicator for overall survi-
val. Furthermore, after Bonferroni adjustment for multiple com-
parisons, tumor grade and geographic region were not statistically
signiﬁcantly associated with overall survival. Univariate analysis
results for categorical variables are presented in Table 2. Kaplan–
Meier product limit curves are provided for age (Fig. 3), marital
status (Fig. 4), and tumor location (Fig. 5).
The ﬁnal multivariable model demonstrated that age (po0.0001),
marital status (p¼0.02), and appendicular or axial tumor location
(p¼0.004) remained signiﬁcant independent prognostic variables for
overall survival (Table 3). A survival advantage was demonstrated for
younger patients. The mortality rate for PLB patients in the 30–59 age
group is estimated to be 4.4 times that for those patients in the o30
age group, after adjusting for marital status and tumor location
(CI: 1.7–11.2; p¼0.002). Furthermore, patients aged 60 or older are
estimated to have a mortality rate 12.8 times that for o30 year-old
Table 1
Descriptive demographic and clinical statistics of the study population.
Characteristic Frequency % Of
total
Total number of patients 692 100.0
Age
o30 67 9.7
30 to 59 240 34.7
60 or greater 385 55.6
Sex
Male 370 53.5
Female 322 46.5
Race
White 616 89.0
Black 45 6.5
Asian, other and unknown 31 4.5
Ethnicity
Non-Spanish–Hispanic–Latino 632 91.3
Spanish–Hispanic–Latino 60 8.7
Marital status
Single 122 18.2
Married 383 57.2
Divorced, separated, widowed 165 24.6
Geographic region
Southeast 54 7.8
South 42 6.1
Midwest 111 16.0
Northeast 94 13.6
West 391 56.5
County
Non-metro county 87 12.6
Metro county 605 87.4
Tumor site
Axial 389 56.2
Appendicular 303 43.8
Histology
Malignant lymphoma, NOSa 46 6.7
Malignant lymphoma, non-Hodgkin, NOSa 75 10.8
Malignant lymphoma, small B lymphocytes, NOSa 21 3.0
Lymphoplasmacytic lymphoma (NHL b) 11 1.6
Malignant lymphoma, mixed small and large cell,
diffuse
22 3.2
Diffuse large B-cell (NHLb) lymphoma 493 71.2
Malignant lymphoma, large B, diffuse, immunoblastic 24 3.5
Grade
B-cell; pre-B; B-precursor 668 96.5
Well differentiated; grade I 6 0.9
Moderately differentiated; grade II 9 1.3
Poorly differentiated; grade III 5 0.7
Undifferentiated; anaplastic; grade IV 4 0.6
Surgery
Yes 177 25.8
No 510 74.2
Radiation
Yes 475 70.6
No 198 29.4
a NOS, not otherwise speciﬁed.
b NHL, non-Hodgkin lymphoma.
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patients, after adjusting for tumor location and marital status
(CI: 5.1–32.3; po0.0001), though this ﬁnding is potentially inﬂuenced
by medical comorbidities.
The multivariable Cox regression model also showed that
patients who were divorced, separated, or widowed had a sig-
niﬁcantly worse outcome than patients who were married or
single; the mortality rate for Divorced, Separated or Widowed PLB
patients was estimated to be 1.4 times that for married patients,
after adjusting for tumor location and age (CI: 1.1–1.8; p¼0.006).
The hazard ratio for comparing single with married patients was
non-signiﬁcant, however (p¼0.69).
Anatomical location of the primary tumor was also a signiﬁcant
factor in overall survival. Patients with an appendicular lesion had
signiﬁcantly better prognosis than patients with a primary axial
lesion (Fig. 6). The mortality rate for PLB patients with axial-
located disease is estimated to be 1.4 times that for those patients
with appendicular-located disease, after adjusting for marital
status and age (CI: 1.2–1.8; p¼0.004).
4. Discussion
The current study presents a population-based analysis of the
effects of demographic factors on overall survival from primary
lymphoma of bone. In order to account for the various clinical
indicators, this study utilized the large patient population to better
analyze the relative prognostic signiﬁcance of patient- and tumor-
related predictors of overall survival from the disease. To our
knowledge, this is one of the largest studies of patients with
primary lymphoma of bone published in the English language
medical literature. Among the strengths of a large, population-
based study is the inclusion of a larger collection of patients than
would be feasible for a single institution study of such a rare
disease, as well as the ability to sample a cross-section of the
United States’ population.
Single institution studies have been published on individual
chemotherapy regimens, as well as the individual prognostic
Fig. 1. Kaplan–Meier plot of overall survival in study population.
Fig. 2. Incidence of primary lymphoma of bone, age-adjusted to the 2000 US
standard population.
Table 2
Univariate analysis of effects on overall survival.
Characteristic 1-Year survival 5-Year survival 10-Year survival p-Valuea
Overall 77.4 49.6 30.2 NAb
Age o .0001n
o30 98.5 NA NA
30–59 85.5 71.8 52.7
460 68.8 30.6 13.9
Sex .24
Male 78.0 49.5 35.6
Female 76.7 49.8 24.5
Race .09
White 77.2 48.2 29.4
Black 82.8 62.2 NA
Other 72.8 63.4 50.7
Ethnicity .40
Non-Hispanic 78.2 50.0 30.7
Hispanic 65.3 45.9 17.8
Marital status o .0001n
Married 79.5 50.5 33.9
Single 86.0 69.0 50.0
Divorced, separated, widowed 66.6 34.3 11.6
Geographic region .02n
Northeast 77.4 50.3 NA
Southeast 73.1 8.1 0
Midwest 73.8 46.3 26.1
West 77.6 54.0 34.9
South 78.8 41.7 34.2
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potentials of several laboratory values (i.e. Lactate Dehydrogenase)
[10,15]. However, the SEER database does not include data on
chemotherapy [17], thus the relative effect of chemotherapy
treatment regimens could not be evaluated in our analysis. We
addressed the concern over evolving chemotherapy protocols by
limiting the study to a 15-year period. While the authors recognize
that signiﬁcant improvements in imaging, staging, and clinical
care have been made over the study period, there was no
signiﬁcant change in the incidence or overall survival over the
course of this study, thereby supporting a stable clinical period for
analysis. Limiting the years of the study also helped control for the
changes in classiﬁcation and categorization of the disease, while
allowing for long-term follow-up for overall survival.
We found that appendicular tumor location is an independent
predictor of survival in multivariable analysis when compared
with axial location. While this has been suggested by previous
authors, other relatively large studies investigating PLB have not
yielded signiﬁcant prognostic importance for overall survival,
when considering confounding variables [8,15]. Age at time of
diagnosis was also an independent predictor of survival, which has
been consistently demonstrated in prior analyses [8,13,14]. Age
over 60 years has previously been shown to inﬂuence both overall
and disease-speciﬁc survival, so these ﬁndings are not entirely
related to mortality from unrelated conditions. However, the
ability to endure chemotherapy due to age and comorbidities
may plan a signiﬁcant role in considering treatment options.
Table 2 (continued )
Characteristic 1-Year survival 5-Year survival 10-Year survival p-Valuea
Tumor location o .0001n
Appendicular 85.6 58.4 33.7
Axial 71.1 43.1 28.4
Histology 1.0
Malignant lymphoma, NOSc 78.0 46.7 32.4
Malignant lymphoma, non-Hodgkin, NOSc 73.2 39.2 NA
Malignant lymphoma, small B lymphocytes, NOSc 69.7 25.7 NA
Lymphoplasmacytic lymphoma (NHLd) 81.8 61.4 NA
Malignant lymphoma, mixed small and large cell, diffuse 80.6 65.1 18.3
Diffuse large B-cell (NHLd) lymphoma 77.9 50.4 31.5
Malignant lymphoma, large B, diffuse, immunoblastic 66.7 51.9 28.8
Grade .24
B-cell; pre-B; B-precursor 77.6 50.4 31.1
Grade I 66.7 NA NA
Grade II 77.8 38.9 NA
Grade III 60.0 NA NA
Grade IV NA NA NA
Surgery 0.19
Yes 78.6 42.1 27.4
No 77.1 52.8 32.3
Radiation 0.79
No 73.2 50.0 29.5
Yes 80.3 49.2 29.9
a p Values are results of the log-rank test, with Bonferroni adjustments made for multiple comparisons.
b NA, not available.
c NOS, not otherwise speciﬁed.
d NHL, non-Hodgkin lymphoma
n Indicates result is statistically signiﬁcant on a 0.05 level of signiﬁcance.
Fig. 3. Kaplan–Meier plot of overall survival related to age at diagnosis. Fig. 4. Kaplan–Meier plot of overall survival related to marital status.
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In the current study, multivariable analysis demonstrated that
divorced, separated, or widowed patients have a signiﬁcantly
poorer prognosis than married patients, independent of age. There
was insufﬁcient data available from the SEER database to elucidate
the cause of this ﬁnding. However, using the SEER database, Aizer
et al., also demonstrated that marital status was an independent
predictor of survival following oncologic diagnoses [20]. They
reported that the survival beneﬁt associated with marriage was
larger than the published survival beneﬁt of chemotherapy for
prostate, breast, colorectal, esophageal and head/neck cancers.
Marital status was associated with lower stage at presentation in
that study [20], suggesting that these ﬁndings may be due to lead
time bias of earlier detection in married patients, rather than a
true reﬂection of improved mortality.
5. Conclusions
In conclusion, there is evidence to suggest that socioeconomic
factors, as well as clinical factors, contribute to the overall survival
in patients with primary lymphoma of bone. Younger age, appen-
dicular tumor location, and being married appear to be good
prognostic factors for survival among patients with PLB.
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Fig. 5. Kaplan–Meier plot of overall survival related to primary tumor location.
Table 3
Multivariable analysis results.
Variable Hazard ratio 95% CIa p-Value
Tumor location
Appendicular Reference group
Axial 1.41 1.12–1.77 0.0035n
Marital status
Married Reference group
D, S, Wb 1.41 1.11–1.79 0.0055n
Single 1.08 0.75–1.56 0.6889
Age
o30 Reference group
30 to 59 4.39 1.72–11.19 0.0019n
60 or greater 12.81 5.08–32.29 o .0001n
a CI, conﬁdence interval.
b D, divorced; S, separated; W, widowed.
n Indicates statistically signiﬁcant on a po0.05 level.
Fig. 6. Multivariate adjusted survival curve comparing tumor location from 1989 to
2003 among married patients, stratiﬁed by age.
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